Stratos Wealth Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,514
| Closed | -$226K | – | 762 |
|
|
2024
Q4 | $226K | Sell |
2,514
-160
| -6% | -$14.4K | 0.01% | 645 |
|
|
2024
Q3 | $264K | Buy |
2,674
+170
| +7% | +$16.8K | 0.01% | 634 |
|
|
2024
Q2 | $232K | Sell |
2,504
-3,306
| -57% | -$307K | 0.01% | 626 |
|
|
2024
Q1 | $551K | Buy |
5,810
+3,063
| +112% | +$291K | 0.03% | 438 |
|
|
2023
Q4 | $245K | Buy |
+2,747
| New | +$245K | 0.01% | 603 |
|
|
2023
Q3 | – | Sell |
-2,665
| Closed | -$222K | – | 721 |
|
|
2023
Q2 | $222K | Hold |
2,665
| – | – | 0.02% | 582 |
|
|
2023
Q1 | $203K | Sell |
2,665
-16,445
| -86% | -$1.25M | 0.02% | 574 |
|
|
2022
Q4 | $1.59M | Buy |
+19,110
| New | +$1.59M | 0.13% | 213 |
|
|
2022
Q3 | – | Sell |
-5,760
| Closed | -$428K | – | 545 |
|
|
2022
Q2 | $428K | Sell |
5,760
-11,292
| -66% | -$839K | 0.04% | 387 |
|
|
2022
Q1 | $1.53M | Buy |
+17,052
| New | +$1.53M | 0.12% | 204 |
|
|
2021
Q3 | – | Sell |
-1,585
| Closed | -$215K | – | 580 |
|
|
2021
Q2 | $215K | Buy |
+1,585
| New | +$215K | 0.02% | 505 |
|
|
2020
Q4 | – | Sell |
-3,622
| Closed | -$404K | – | 408 |
|
|
2020
Q3 | $404K | Buy |
+3,622
| New | +$404K | 0.1% | 212 |
|
|
2020
Q2 | – | Sell |
-774
| Closed | -$60K | – | 378 |
|
|
2020
Q1 | $60K | Buy |
+774
| New | +$60K | 0.04% | 184 |
|